143 related articles for article (PubMed ID: 31774712)
41. Preventing HIV transmission in "priority" countries.
Finger WR
Netw Res Triangle Park N C; 1993 May; 13(4):18-21. PubMed ID: 12344871
[TBL] [Abstract][Full Text] [Related]
42. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
Gil M; Ramil F; AgÍs JA
Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
[TBL] [Abstract][Full Text] [Related]
43. Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.
Mukakalisa I; Bindler R; Allen C; Dotson J
Health Care Women Int; 2014; 35(7-9):1065-80. PubMed ID: 24750113
[TBL] [Abstract][Full Text] [Related]
44. [New paradigms and challenges in cervical cancer prevention and control in Latin America].
Almonte M; Murillo R; Sánchez GI; Jerónimo J; Salmerón J; Ferreccio C; Lazcano-Ponce E; Herrero R
Salud Publica Mex; 2010; 52(6):544-59. PubMed ID: 21271014
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore.
Tay SK; Lee BW; Sohn WY; Lee IH; Mathur G; Sanicas M; Van Kriekinge G
Singapore Med J; 2018 Jul; 59(7):370-382. PubMed ID: 28983579
[TBL] [Abstract][Full Text] [Related]
47. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
[TBL] [Abstract][Full Text] [Related]
48. Cervical cancer in Latin America.
Eluf-Neto J; Nascimento CM
Semin Oncol; 2001 Apr; 28(2):188-97. PubMed ID: 11301382
[TBL] [Abstract][Full Text] [Related]
49. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
Bosch FX; Tsu V; Vorsters A; Van Damme P; Kane MA
Vaccine; 2012 Nov; 30 Suppl 5():F1-11. PubMed ID: 23199951
[TBL] [Abstract][Full Text] [Related]
50. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
51. Human papillomaviruses: The cervical cancer saga in developing countries.
Alhamlan FS; AlAhdal MNA; Al-Zahrani AS; Almatrrouk SA
J Infect Dev Ctries; 2017 Dec; 11(11):819-825. PubMed ID: 31618179
[TBL] [Abstract][Full Text] [Related]
52. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
54. HPV vaccine introduction in Rwanda: Impacts on the broader health system.
Torres-Rueda S; Rulisa S; Burchett HE; Mivumbi NV; Mounier-Jack S
Sex Reprod Healthc; 2016 Mar; 7():46-51. PubMed ID: 26826045
[TBL] [Abstract][Full Text] [Related]
55. Cervical cancer in Latin America and the Caribbean: the problem and the way to solutions.
Villa LL
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1409-13. PubMed ID: 22956726
[TBL] [Abstract][Full Text] [Related]
56. Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
Ogilvie G; Nakisige C; Huh WK; Mehrotra R; Franco EL; Jeronimo J
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():15-19. PubMed ID: 28691338
[TBL] [Abstract][Full Text] [Related]
57. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
58. An overview on the implementation of HPV vaccination in Europe.
Bonanni P; Levi M; Latham NB; Bechini A; Tiscione E; Lai P; Panatto D; Gasparini R; Boccalini S
Hum Vaccin; 2011; 7 Suppl():128-35. PubMed ID: 21245659
[TBL] [Abstract][Full Text] [Related]
59. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.
Luciani S; Andrus JK
Reprod Health Matters; 2008 Nov; 16(32):59-66. PubMed ID: 19027623
[TBL] [Abstract][Full Text] [Related]
60. Cervical cancer burden and prevention strategies: Asia Oceania perspective.
Garland SM; Bhatla N; Ngan HY
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1414-22. PubMed ID: 22956727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
